share_log

HC Wainwright & Co. Initiates Coverage On Blue Water Vaccines With Buy Rating, Announces Price Target of $7

HC Wainwright & Co. Initiates Coverage On Blue Water Vaccines With Buy Rating, Announces Price Target of $7

HC Wainwright & Co.以买入评级启动对蓝水疫苗的报道,宣布目标价为7美元
Benzinga Real-time News ·  2022/12/09 06:11

HC Wainwright & Co. analyst Vernon Bernardino initiates coverage on Blue Water Vaccines (NASDAQ:BWV) with a Buy rating and announces Price Target of $7.

HC Wainwright & Co. 分析师弗农·贝纳迪诺以买入评级开始对蓝水疫苗(纳斯达克股票代码:BWV)进行报道,并宣布目标价为7美元。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发